Literature DB >> 6868096

Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India.

T K Jha.   

Abstract

Pentamidine isethionate was found to be a very effective therapeutic agent in the treatment of pentavalent antimonial-resistant cases of kala-azar. Cardiotoxicity and metabolic disturbance (diabetes mellitus-like state) were found to be limiting factors in the use of this drug. Frequent clinical, electrocardiographic and biochemical observations are required during and after course of treatment and pentamidine treatment should be restricted to in-patients in hospitals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6868096     DOI: 10.1016/0035-9203(83)90058-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  19 in total

1.  Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening.

Authors:  Suman Gupta; Shyam Sundar; Neena Goyal
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Pentamidine reduces hERG expression to prolong the QT interval.

Authors:  Jason S Cordes; Zhuoqian Sun; David B Lloyd; Jenifer A Bradley; Alan C Opsahl; Mark W Tengowski; Xian Chen; Jun Zhou
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 3.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Chemotherapy of leishmaniasis in India.

Authors:  C P Thakur
Journal:  Indian J Pediatr       Date:  1987 Jan-Feb       Impact factor: 1.967

Review 5.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

6.  Severe ventricular arrhythmia during pentamidine treatment of AIDS-associated Pneumocystis carinii pneumonia.

Authors:  T Loescher; K Loeschke; J Niebel
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

7.  Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.

Authors:  Swati Pal; Rajesh Ravindran; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Drug resistance in leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  J Glob Infect Dis       Date:  2010-05

Review 9.  Leishmaniasis.

Authors:  Tonio V Piscopo; Charles Mallia Azzopardi
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

10.  Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.

Authors:  S Kar; K Kar; P K Bhattacharya; D K Ghosh
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.